Similar Articles
Use of Clozapine in the Treatment-Resistant Schizoprenia
Oğuzhan Kütük
DOI: 10.5606/jebms.2020.75609
Issue: 2020, Volume 1 - Issue 1
1226
1027
Glucagon-Like Peptide-1 and Psychiatric Disorder
Ayşe Şiva Acar, Oytun Erbaş
DOI: 10.5606/jebms.2021.75645
Issue: 2021, Volume 2 - Issue 2
2480
1704
Brain-Derived Neurotrophic Factor (BDNF) Polymorphism and Depression-Suicide
İlayda Üzümcü, Oytun Erbaş
DOI: 10.5606/jebms.2021.75654
Issue: 2021, Volume 2 - Issue 2
806
653
Synaptic Vesicle Protein 2A: Basic Facts and Roles in Schizophrenia
Aylin Kayaaltı, Berzah Güneş, Oytun Erbaş
DOI: 10.5606/jebms.2021.75677
Issue: 2021, Volume 2 - Issue 3
1416
542
Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review
Dildar Savcı, Sultan Karadeniz, Oytun Erbaş
DOI: 10.5606/jebms.2021.75683
Issue: 2021, Volume 2 - Issue 3
723
668
Gluten and Casein: Their Roles in Psychiatric Disorders
Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş
DOI: 10.5606/jebms.2022.1003
Issue: 2022, Volume 3 - Issue 1
6268
1599
Understanding the Role of DISC1 in Psychiatric Disorders
Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş
DOI: 10.5606/jebms.2022.1011
Issue: 2022, Volume 3 - Issue 1
937
538
Schizophrenia Susceptibility Genes
Beyza Nur Akı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1027
Issue: 2022, Volume 3 - Issue
637
579
An Overview of Antipsychotics: Mechanisms of Action
Öznur Demirci, İrem Adar, Oytun Erbaş
DOI: 10.5606/jebms.2023.1047
Issue: 2023, Volume 4 - Issue 1
2240
998